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Chapter 1: Literature Review 
General Introduction 
Leishmania protozoan parasites are endemic in 88 countries and are the causal agents 
of leishmaniasis, a parasitic infection that has 4 different clinical presentations: cutaneous 
(CL), diffuse cutaneous (DCL), mucocutaneous (ML), and visceral (VL). Parasites are 
transmitted through bloodmeals of infected Phlebotomus spp. sand flies to vertebrate hosts 
[1]. There are anywhere from 1 to 1.5 million cases of CL contracted every year, with 90% of 
those cases found in Afghanistan, Algeria, Brazil, Iran, Peru, Saudi Arabia and Syria. VL is 
less prevalent but more serious due to the likelihood of fatality if left untreated. There are 
approximately 500,000 new cases in humans annually, with approximately 90% of those 
occurring in Bangladesh, India, Nepal, Sudan and Brazil [2-3]. The species of Leishmania 
that will be studied for this thesis research is Leishmania chagasi, one of the causative agents 
of VL found primarily across South America [4-5]. The importance of studying pathogenic 
mechanisms of L. chagasi is to ascertain involvement of parasite molecules for potential 
exploitation as drug targets or vaccine candidates. 
Life Cycle 
L. chagasi has a digenetic lifecycle, where it exists as a free living, flagellated form, 
termed the promastigote in the sand fly vector and in the vertebrate host the parasite exists as 
a small, ovoid, non-flagellated and non-motile form termed the amastigote. The amastigote is 
an obligate intracellular parasite of professional phagocytic cells, such as macrophages, and 
survives within phagolysosomes. 
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Once ingested by the sand fly as part of a bloodmeal, L. chagasi amastigotes enter the 
abdominal portion of the midgut, where the blood stimulates the formation of a peritrophic 
membrane around the bloodmeal, made up of a chitinous protein matrix secreted by the 
epithelial cells of the midgut [6]. This membrane is fully formed around the bloodmeal 
within 24 hours of ingestion and acts as a permeable barrier that prevents the contents of the 
bloodmeal from interacting with the parasite midgut, while allowing for the entry of digestive 
enzymes within the peritrophic matrix allowing for digestion over the course of 4-5 days [6]. 
After 24 hours post bloodmeal, amastigotes transform to procyclic promastigotes, 
characterized by their short flagella and ovoid shape. Procyclic then transform to a more 
slender, rapidly dividing stage called nectomonads, over the next 2-3 days. The nectomonads 
accumulate at the anterior portion of the midgut, and attach to the midgut epithelium after 
disintegration of the peritrophic matrix. This allows the parasites to avoid excretion allowing 
for migration to the thoracic midgut. After 4-5 days post bloodmeal, nectomonads are 
replaced by 2 different forms in the thoracic midgut, the heptomonads and the metacyclics [1, 
7-11]. Metacyclic forms, as previously described, are the infectious, non-dividing form of the 
parasite that establishes infection in the vertebrate host. Haptomonads are shown to adhere to 
the stomodeal valve (the valve that separates the proventriculus from the mid gut), and 
secrete filamentous proteophosphoglycan (fPPG) forming a plug made up of both parasites 
and fPPG [12-18]. It is thought that this thick plug inhibits the ability of the vector to feed by 
preventing the pharyngeal and cibarial pumps from properly functioning, affecting the sand 
fly’s ability to engorge during a bloodmeal. This leads to increased probing which results in 
more sites of infection [19-21]. The metacyclic parasites are not contained in this plug and 
continue to migrate toward the anterior of the sand fly, in prime position for egestion from 
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the sand fly into the blood stream of the vertebrate host. The number of metacyclic parasites 
egested by the sand fly per probe is anywhere from 100-1000 parasites, which has been 
shown to be enough parasites to establish infection [20]. 
Complement Cascade 
After introduction into the vertebrate host, metacyclic promastigotes are immediately 
exposed to the complement system, which resides in the blood and is constitutively active. 
The complement system is a series of zymogens that bind the parasite surface and create an 
amplification loop of events that culminate in pore formation in the cell membrane that can 
result in cell lysis, a process that metacyclic promastigotes must evade to establish infection 
in vertebrates. The complement system can be activated to attack a microbe through three 
different pathways: classical, mannose binding lectin (MBL), and alternative. The alternative 
pathway is the best studied in Leishmania infections, though it has been shown that the MBL 
pathway contributes to complement deposition on Leishmania major, Leishmania mexicana 
and Leishmania braziliensis [22-23].  Briefly, the alternative pathway of complement is 
active when complement protein C3 undergoes spontaneous hydrolysis of C3 to C3b and C3a 
in the serum of vertebrate blood. C3b is bound to the pathogen surface, while C3a remains in 
the serum/blood [24]. Ultimately the three pathways converge upon deposition of 
complement protein C3b on the parasite surface, which has 2 main functions. 
The first function of C3b is the formation of the membrane attack complex (MAC). 
Surface deposited C3b recruits additional C3 to the pathogen surface where it is cleaved into 
additional C3b molecules. Two units of C3b form the C5 convertase protein which cleaves 
C5 into C5a and C5b, neither of which is bound to the parasite [24]. C5b forms a complex 
with C6, and then C7 (C5b67), which is then anchored to the parasite surface. C8 then binds 
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to this C5b67 complex inserting itself into the membrane of the pathogen, allowing for 
polymerization of 10-16 C9 molecules that forming the pore known as the MAC. If enough 
MACs are inserted into the parasite cell membrane, it will lead to cell lysis and death [24]. 
The second function of C3b is as a ligand for complement receptors 1 (CR1) and 3 
(CR3) [24] that are present on professional phagocytic cells, including macrophages. The 
interaction of CR1 and CR3 with C3b has been shown to promote phagocytosis, though this 
binding alone is not sufficient for phagocytosis [25]. Protein C3a and C5a are two examples 
of complement proteins that are anaphylatoxins, which act to generate a local inflammatory 
response directed towards the pathogen by recruiting multiple immune cell types such as 
endothelial cells, mast cells, and phagocytic cells that aid in the removal of the pathogen 
primarily by phagocytosis. In addition, C3a and C5a bind their respective receptors present 
on macrophages and in conjunction can promote the phagocytosis of parasites already bound 
to the CR1 or CR3 receptors [24, 26].  
Leishmania parasites enter the host as metacyclic promastigotes but do not propagate 
as extracellular parasites. The deposition of complement proteins onto parasites, termed 
opsonization, is essential for parasite uptake into its preferred environment, the lysosomes of 
phagocytic cells. The ability to have complement proteins present on the parasite surface 
without the insertion of a MAC allows for Leishmania to survive the complement cascade, 
but also ensures phagocytosis by macrophages. It has been demonstrated that non-metacyclic 
and metacyclic L. major promastigotes both bind C3 equivalently, however the amount of C9 
bound to non-metacyclics is significantly more than that of metacyclics [27-28]. This is 
attributed to spontaneous release of the MAC into the serum by metacyclic cells suggesting 
that metacyclics are capable of releasing or shedding the C5b-9 complex, ultimately evading 
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CML, while non-metacyclic cells do not [28-29]. Metacyclic cells have shown the ability to 
evade CML in numerous species of Leishmania and this ability is attributed to their surface 
molecules, though many of the mechanisms used by the different surface molecules are not 
known. 
Surface molecules 
Lipophosphoglycan (LPG) 
Lipophosphoglycan (LPG) is a surface glycoconjugate that is the most abundant surface 
molecule on Leishmania [30-31]. The LPG molecule includes a glycosylphosphatidylinositol 
(GPI) lipid anchor, glycan core, phosphorylated oligosaccharide repeats, and an 
oligosaccharide cap. Non-metacyclic LPG in L. major contains 14-30 less oligosaccharide 
repeats than the metacyclic counterpart, effectively doubling the length of LPG in 
metacyclics [30]. Additionally, the side chains that branch off of the oligosaccharide repeats 
and terminal oligosaccharide cap are also modified [30-31]. LPG on non-metacyclics acts to 
bind the midgut of the sand fly preventing egestion of the parasite [32-33]. LPG on 
metacyclics has been extensively studied, and it is a prominent virulence factor.  
LPG in  L. major has high affinity for C3 of the parasite surface molecules as shown by 
immunoprecipitation of radiolabeled C3 with LPG [29]. When LPG is genetically knocked 
out from metacyclic promastigotes of L. major,  the parasites are no longer able to withstand 
CML [34]. Other studies have indicated that LPG forms a thick protective layer known as the 
glycocalyx that is thought to act as a barrier from the extracellular environment and possibly 
MACs [35], and that LPG purified from L. major and L. donovani can even down-regulate 
macrophage function by preventing full function of macrophages after LPG exposure [36].  
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Major Surface Protease (MSP) 
The second most abundant surface molecule is GP63, also known as Major Surface 
Protease (MSP). MSP  has been identified in all the species of Leishmania that have been 
studied [37-38] and has been identified as a zinc-containing metalloprotease [39]. Antibody 
fragments against MSP were used to inhibit its interaction with macrophage receptors and 
prevented the binding and uptake of L. mexicana parasites with macrophages by 30-35% 
[40]. In vitro assay of MSP activity converts C3b to iC3b; the iC3b protein is not capable of 
initiating MAC formation, yet  acts as a binding enhancer for the process of phagocytosis, 
known as an opsinogen [41]. When MSP is genetically knocked out of L. major parasites, so 
is the ability to resist CML [42]. 
Promastigote Surface Antigen 
GP46, also known as Promastigote Surface Antigen (PSA) is another abundant 
surface glycoprotein that is expressed by many species of Leishmania promastigotes, but has 
no known function. PSA contains a leucine rich repeat (LRR) motif, [43] which has been 
shown in other proteins to exist in a highly folded, horseshoe shaped structure that has a high 
surface area conducive to protein-protein interactions [44]. LRRs are commonly used for 
pathogen recognition by plants and vertebrates and are most well known for being the main 
pathogen recognition motif in the Toll-like receptor (TLR) system of vertebrate phagocytes 
[45-46]. There are between 3-13 LRR repeats each made up of 24-25 amino acids, and have 
been found in PSA protein sequences of L. major, L. amazonensis, L. infantum, and L. 
chagasi [47-51].  It was shown that the region of L. infantum PSA containing 11 LRRs 
(produced recombinantly) was recognized by all sera recovered from canines naturally 
infected with L. infantum, compared to 25% recognition of the fully intact parasite derived 
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PSA. The recognition of the PSA LRR by infected canines, the structure of LRRs, high 
abundance of PSA as a surface molecule, and the presence of PSA as a genetic element 
across numerous species of Leishmania, strongly suggests an important role for PSA in host 
infection.  
Numerous studies, to date, have been done to elucidate PSA’s function and potential 
in parasite virulence. For instance, the PSA gene from L. amazonensis was expressed in a 
Vaccinia virus system and used to immunize L. amazonensis susceptible mice. These mice 
were protected from infection with L. amazonensis to such a high degree that there was 
complete clearing of parasites from infected mice 8 months to a year post-immunization, as 
well as no clinical signs of infection [52]. PSA purified from L. major was able to illicit 
immunity in mice and confer some protection from infection, though the larger the parasite 
inoculum, the larger the decrease in protection was observed [53]. Recombinant PSA 
molecules have also been found to interact with macrophages via CR3. PSA uptake by 
macrophages could be inhibited by exposing macrophages initially to CR3 antibodies 
previous to PSA [54]. Additionally, attenuated  L. chagasi that have lost CML resistance and 
production of the PSA protein, can be recovered via transfection with a construct encoding 
recombinant PSA [55]. These studies suggest that PSA is involved with the virulence of 
Leishmania, but its role in virulence is not known. 
MSP and PSA are both molecules seen in numerous species of Leishmania parasites 
[43, 56] and are the two most abundant molecules seen on the parasite surface after LPG. The 
majority of functional studies done with both molecules have been generally in systems that 
do not involve Leishmania parasites and sometimes not even MSP or PSA synthesized in 
Leishmania. MSP expressed on the surface of Chinese hamster ovary cells has been shown to 
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cleave C3b to iC3b when produced by and incubated with C3b; the only indication of 
interaction of MSP with C3b is the formation of its cleavage product iC3b [57]. MSP has 
been shown to be integral to the ability to evade CML, as shown through genetic knockouts 
of MSP that are susceptible to CML [42]. What is not known is if MSP actually interacts 
with any complement proteins; it must interact with C3b to convert it to iC3b, but the 
characteristics of that interaction have not been studied. It also has not been reported whether 
or not MSP interacts with any other complement proteins besides C3b; one study attempted 
immunoprecipitation of C3 using MSP and anti-MSP-sera, but failed to detect interaction 
[29].  PSA has only been associated with virulence through its loss of expression in 
attenuated cell lines of Leishmania, and with re-expression of PSA corresponding with 
recovery of resistance to CML [55]. Studies done with recombinant PSA indicated that it can 
be phagocytosed by cells expressing only CR3 and not through other protein-protein 
interaction techniques [54]. In summary, based on studies to date, parasite surface MSP and 
PSA have not been found to interact with complement proteins, although genetic studies have 
shown their importance in resistance to CML. 
Studies in this thesis will try to determine if interactions between MSP and PSA and 
complement proteins can be detected in a native gel system, and to further characterize C3, 
C5, and C9 complement proteins found in logarithmic and stationary growth phase L. 
chagasi. MSP, PSA, or the complement proteins have not been studied in a gel that does not 
perturb non-covalent interactions. Preliminary studies show that complement proteins C3, 
C5, and C9 are present in high amounts on both log and stationary phase cells after exposure 
to naïve human serum; this validates the ability of L. chagasi cells to bind detectable amounts 
of complement proteins for assessment in downstream studies. 
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Sodium-dodecyl-sulfate polyacrylamide-gel-electrophoresis (SDS-PAGE) is a 
common technique used separate proteins by size. SDS is an anionic detergent that denatures 
proteins, abolishing their secondary and tertiary structure, unfolding them, and coating them 
with a negative charge that allows for separation by size using PAGE. Commonly used with 
SDS is dithiothreitol (DTT), a strong reducing agent that has the ability to break disulfide 
bonds. The types of interactions that are interrupted by SDS also include non-covalent bonds 
that are commonly used in interactions of proteins with other proteins.  
The majority of the studies that involve parasite proteins and complement proteins 
have all used reducing SDS-PAGE to resolve proteins, a technique that interrupts weaker 
protein interactions that may be involved. Studies using MSP to immunoprecipitate C3 had 
SDS present in the buffer, so if non-covalent interactions between C3 and MSP exist, they 
were disrupted [29].  
Blue Native PAGE is a technique used originally to separate the hydrophobic 
membrane proteins of mitochondria, but has been used in a number of applications [58]. 
Traditional native PAGE generally relies on separating proteins by their isoelectric point (pI) 
through gels of a specific pH value; this format has been tried using multiple pH values for 
gels and were unable to resolve Leishmania proteins (Ramer-Tait, unpublished data). Blue 
Native PAGE uses Coomassie G-250, an amphiphillic molecule, to negatively charge 
proteins in a non-denaturing method to ensure separation of proteins by size. This technique 
will allow for resolution of the complex Leishmania surface molecules in a native gel format 
that does not interrupt non-covalent bonds. Proteins resolved using Blue Native PAGE still 
have to be solubilized using a detergent, and non-ionic detergents are preferred, because their 
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lack of charge allows for avoidance of disruption of non-covalent protein-protein 
interactions. 
Triton X-114 is a non-ionic detergent made up of lipid molecules and has been widely 
used in Leishmania to isolate GPI anchored proteins [59-63]. The mechanism by which 
Triton X-114 enriches for GPI anchor proteins is based on the formation of lipid micelles. 
These micelles form at a specific temperature known as a cloud point, so named because the 
detergent becomes cloudy due to the micelles that form at this temperature. Once the cloud 
point is reached, the micelles incorporate GPI anchored proteins, and are harvested by 
centrifugation [63]. The reason the detergent fractions are of interest is because of the high 
number of GPI anchored molecules on the surface of the parasite, which is where the 
majority of complement proteins would be expected to be found. The ability to separate GPI 
anchored surface molecules from other proteins could give insight to mechanisms involved 
with CML, as well as determining if complement proteins interact primarily with surface 
molecules.  
To date, a total of 4 parasite surface molecules have been implicated in the ability of 
the parasite to evade complement: LPG, MSP, PSA and PPG [18, 55, 64-68]. When LPG and 
MSP are deleted, or when PSA expression is lost, parasites no longer resistance CML; this 
indicates that the parasite uses multiple mechanisms to evade CML. Parasite surface 
molecules are likely not the only molecules involved with the resistance to CML, but so far 
are the only molecules implicated. As described in Chapter 4, a genetics approach was used 
towards the identification of new molecules that are involved with complement evasion.  
These experiments utilized a functional screen of CML susceptible cells complemented with 
a genomic library made from DNA of a CML resistant parasite strain. Although never 
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previously used in regards to CML resistance, functional complementation of Leishmania has 
been used successfully to isolate genetic mutations associated with other phenotypes [69-72]. 
Complementation of attenuated L. chagasi with genomic DNA from virulent L. chagasi, 
which were exposed to serum after transfection, yielded 12 clones containing approximately 
35 kDa genomic DNA inserts, none of which contained DNA sequence from MSP or PSA 
[73-74]. Three clones were further characterized through complete sequencing of their inserts 
and subcloning of different DNA fragments followed by transfection into attenuated cell 
lines to asses for the ability to survive CML. 
 
12 
 
Chapter 2: Analysis of serum exposure effects on surface proteins of Leishmania chagasi, 
and on human serum complement proteins C3, C5, and C9 deposited on the parasite surface 
 
 Abstract: 
 
 Leishmania spp. promastigotes that have been cultured in vitro exhibit variable 
resistance to complement mediated lysis (CML) that is dependent on their stage in 
development and on the culture growth stage. Leishmania chagasi promastigotes in 
logarithmic (log) phase of growth are sensitive to CML while promastigotes in the stationary 
phase of growth are resistant to CML. Two different types of PAGE were utilized to asses 
serum-exposed log and stationary phase promastigotes for evidence of interaction (i.e. 
change in protein gel mobility) between abundant L. chagasi surface proteins and serum 
complement proteins. Analysis by reducing SDS-PAGE and Blue Native PAGE failed to 
detect any differences in the gel mobility of two abundant parasite surface proteins, major 
surface protease (MSP) and promastigote surface antigen (PSA), after cell exposure to serum. 
Similarly, identical isoforms of C5 were observed in log and stationary phase cells that were 
assessed by both PAGE methods. C9 had identical isoforms in log and stationary phase 
parasite fractions when resolved with both PAGE systems; however, a low mobility C9 band 
observed in Blue Native PAGE was stronger in stationary phase cell fractions than in log 
phase cells. Resolution of C3 with Blue Native PAGE detected multiple bands including one 
that shifted in mobility between stationary and log phase cells, while SDS-PAGE analysis 
detected a number of banding differences in log versus stationary cell extracts.  In additional 
experiments using both PAGE techniques, C9 isoforms were determined in serum that was 
pre-exposed to log or stationary phase cells.  These serum-only fractions contained a number 
of different C9 isoforms that exhibited variability under Blue Native PAGE analysis but not 
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under SDS-PAGE analysis.  By Blue Native PAGE, serum pre-exposed to stationary cells 
contained almost exclusively a largely immobile isoform, serum pre-exposed to log cells 
contained a lesser amount of that low mobility isoform as well as a number of higher 
mobility isoforms, and control serum (not pre-exposed to cells) contained almost exclusively 
higher mobility isoforms that migrated equivalently to those in log-exposed serum but were 
at higher abundance.   
Introduction: 
 
Leishmania spp. are protozoan parasites of the family Trypanosomatidae that cause a 
condition known as leishmaniasis that has multiple clinical manifestations each of which are 
caused by different species, with the most severe manifestation being visceral leishmaniasis. 
These parasites have a digenetic lifecycle in which they exist as a flagellated promastigote in 
the sand fly insect vector and an immobile, ovoid amastigote form within phagocytic cells of 
the vertebrate host. The cycle begins when a female sand fly feeds on blood from an infected 
vertebrate, ingesting amastigote-infected phagocytic cells that shortly lyse, expelling 
amastigotes into the sand fly midgut. The parasite morphology changes from amastigote to 
promastigote in the first few days of infection, then promastigotes undergo a series of 
intermediate morphological steps that result in metacyclic promastigotes, which is the final 
and highly infective stage of Leishmania [75-76]. The process and sequence of 
morphological and molecular changes that give rise to metacyclic promastigotes is termed 
metacyclogenesis [75]. There are a number of molecular changes the parasite undergoes in 
metacyclogenesis, such as increases in length and/or glycosylation state of the most abundant 
surface molecule of Leishmania, lipophosphoglycan (LPG) [8, 30], and increases in 
abundance of two highly abundant surface proteins, major surface protease (MSP) [77] and 
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promastigote surface antigen (PSA) [78]. Metacyclogenesis of Leishmania can be modeled in 
axenic cell culture, with procyclic and metacyclic promastigotes typically found in an 
infected sand fly corresponding to those found in parasite cultures at logarithmic (log) or 
stationary phase of growth, respectively [66, 79-80]. 
  Metacyclic promastigotes are the primary form of Leishmania transmitted by the sand 
fly bite to the vertebrate host, and upon their entry to the host bloodstream are immediately 
exposed to the host’s complement system, a component of the innate immune system. The 
complement system is a series of zymogens, or proenzymes, that bind pathogens to clear 
them from the bloodstream through opsonized uptake by phagocytes or by completion of the 
complement cascade which forms a pore in the pathogen membrane called a membrane 
attack complex (MAC). If enough MACs form they will disrupt the pathogen cell membrane 
resulting in complement mediated lysis (CML). Metacyclic promastigotes are able to resist 
and evade the complement system. Studies have shown that surface molecules of Leishmania 
are used to evade CML and also to exploit it to enhance uptake by phagocytic cells. 
Lipophosphoglycan, through changes in its glycosylation state (different sugar molecules 
decorate metacyclic LPG versus procyclic LPG in Leishmania major) and increased length 
after metacyclogenesis, is thought to help evasion of complement lysis by shedding of the 
MAC or adsorption distal to the cell membrane [28, 31, 81]. Major surface protease, present 
in greater amounts in metacyclics versus procyclics [77, 82-83], is thought to contribute to 
complement evasion  through its activity as a zinc-metalloprotease [84], cleaving C3b to 
inactive C3b (iC3b). This proteolysis may benefit the parasite in two ways; it stops the 
complement MAC formation and produces iC3b, a very strong opsinogen that drastically 
increases the phagocytosis of parasites into macrophages [41].  PSA has no known function, 
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though its expression is shown to be associated with the ability to resist CML. Leishmania 
cell lines exhibiting reduced PSA expression [66] were susceptible to CML in the stationary 
phase of growth that normally is resistant to CML, and recovery of CML resistance was 
observed upon re-expression of recombinant PSA. This indicates the possible involvement of 
PSA in CML evasion [55, 66].  
The following studies sought to identify parasite molecules that bind complement 
proteins and to characterize complement proteins adsorbed to the different forms of parasites 
present in log and stationary cell cultures. These studies assessed the electrophoretic mobility 
of parasite surface molecules or human serum complement proteins as a function of parasite 
exposure to human serum. 
Materials and Methods: 
Parasites: 
Infectious L. chagasi promastigotes were originally obtained as amastigotes from a 
patient with visceral leishmaniasis from Brazil (strain MHOM/BR/00/1969) and maintained 
in male Golden Syrian hamsters, as described [85].  Amastigote-derived  promastigotes were 
maintained in culture using HOMEM media, as described [86]. Cultures of promastigotes 
were seeded at 2.0 x 106 cells/ml and again to the same cell density after 7 days. Logarithmic 
(log) phase cell cultures are cultures 2-3 days after passage with a cell density of 0.6-1.2 x 
107 cells/ml, and stationary phase cells are cultures 5-7 days after passage with a cell density 
of 4-5 x 107 cells/ml. 
Naïve Human Serum: 
Human serum was pooled from the blood of multiple donors. Blood was drawn from 
the donors into serum separator tubes (Corvac serum separator tube 12.5ml draw, Tyco 
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Healthcare Group, Mansfield, Maryland), incubated at 1 hr at room temperature, then 
incubated for 90 minutes at 4°C on ice, and centrifuged at 450 x G for 10 minutes at 4°C. 
Then serum fractions from the separator tubes from each individual were pooled, aliquoted, 
and stored at -80°C. Aliquots from different donors were then thawed on ice, pooled then 
aliquoted, and stored at -80°C until use. 
Complement Lysis Assay: 
Log phase or stationary phase L. chagasi promastigotes were pelleted by 
centrifugation at 2000 x G for 10 minutes, washed in 10 ml phosphate-buffered saline (PBS, 
137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4) and resuspended to 
2.0 X 108 cells/ml.  Aliquots of cells (0.5ml) were brought up to 1 ml in volume with PBS or 
25% naïve human serum and incubated at 37°C for 30 minutes. After incubation cells were 
assessed for survival based upon motility and morphology under light microscopy using a 
hemocytometer. Percent survival was calculated as the ratio of cell densities of the cell serum 
treated cells: cell density of untreated cells. 
Cell Lysis and Triton X-114 Phase Separation: 
Following complement assays, parasites were pelleted using centrifugation at 5000 X 
G for 2 minutes. Only supernatants containing serum were saved (i.e. “washes” were 
discarded). Cell pellets were washed three times in 0.5 ml of PBS, then resuspended in 0.5ml 
1% Triton X-114 (100%, Sigma-Aldrich, St. Louis, Missouri) and rotated at 4°C for 2 hours 
to lyse the cells. An aliquot of the cell lysate was removed and flash frozen with liquid 
nitrogen until PAGE analysis. Remaining total lysates were then centrifuged at 14,000 X G 
for 10 minutes at 4°C to remove insoluble material. Supernatants were layered over 0.6 ml 
6% sucrose 0.06% Triton X-114 (in PBS) cushion and incubated on ice for 10 minutes. 
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Samples were then transferred to a 37°C heating block for 10 minutes until layered lysates 
became cloudy, and were then centrifuged at room temperature at 10,000 X G for 3 minutes. 
Fractions were then separated as follows: the top 0.5 ml of liquid was removed as the 
aqueous phase; the remaining liquid, the sucrose cushion, was removed until just before 
interface between the cushion and the oily detergent pellet. The remaining detergent pellet 
was reconstituted up to 0.5 ml with ice cold PBS and vortexed until thoroughly mixed. Each 
fraction was flash frozen with liquid nitrogen and stored at -20°C until PAGE analysis. See 
Figure 2 for diagram of phase separation scheme. 
Preparation of 1% Triton X-114 Detergent Lysis Buffer in PBS: 
Triton X-114 (100%, Sigma-Aldrich, St. Louis, Missouri) was diluted 1:50 in cold 
PBS (1 ml detergent and 49 mL PBS) and incubated at 4ºC with gently rocking until the 
solution was clear. The diluted detergent was then incubated in a 37°C water bath until 
cloudy; the solution was inverted multiple times to ensure even temperature. Phase 
separation was allowed to occur overnight at 37ºC.  After the detergent phase settled to the 
bottom of the tube and excess aqueous phase (approximately 40-45 ml) was discarded. Ice 
cold PBS was again added and the process repeated 3 times.  After removal of the aqueous 
phase, the detergent was brought to 10 ml total volume in PBS to yield a stock solution of 
pre-condensed 10% Triton X-114 in PBS. A 1:10 dilution of 10% Triton X-114 was made to 
yield the 1% Triton X-114 lysis buffer. All Triton X-114 solutions were stored at 4°C. The 
above protocol was based on Bordier et al. 1981 [63]. 
Blue Native PAGE: 
Samples were separated by Blue Native polyacrylamide gel electrophoresis (PAGE) 
using a 10% resolving gel using a Thermo EC-120 electrophoresis mini-gel apparatus 
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(Thermo Scientific, Rochester, New York). Conditions for Blue Native PAGE were slightly 
modified from the protocol outlined in Wittig et al. 2006 as follows: a 6x Blue Native PAGE 
loading dye was used (300 mM NaCl, 6 mM EDTA, 300 mM Imidazole-HCl pH7.0, 12 mM 
6-aminohexanoic acid, 30% glycerol, 1.2% Coomassie G-250, and 0.3% pre-condensed 
Triton X-114) and a 30% bis-acrylamide stock was used [58]. One µg of total protein as 
determined by the bicinchoninic acid assay (BCA assay, Pierce, Rockford, IL) was loaded 
per lane. Samples were first electrophoresed at 50 V until migration into stacking gel and 
then voltage was increased to 100 V. Once the dye front migrated approximately 1/3 of the 
way through the resolving gel (equivalent to a total run time of 1 hour), the primary cathode 
buffer was replaced with the secondary cathode buffer. The high percentage of Coomassie in 
the primary cathode buffer (0.02% vs. 0.002% in the secondary buffer) inhibits protein 
transfer [58]. The gels were run until the dye front reached the bottom of the gels (about 3-4 
total hours run time), and either silver stained to assess protein loading (using the 
SilverSNAP staining kit, Pierce, Rockford, IL) or electro-transferred to 0.45µm pore size 
polyvinylidene fluoride membrane (PVDF, Millipore Immobulon-P, Billerica, 
Massachusetts). Note: detergent fractions in 6x loading buffer were diluted 1:1 with 1x 
loading buffer prior to electrophoresis to prevent detergent-effects on protein mobility. 
SDS-PAGE: 
Samples were separated using 10% separating SDS-PAGE gels [87] and 
electrophoresed at 140 volts for 1 hour and 10 minutes. After electrophoresis the gels were 
either silver stained using the SilverSNAP staining kit (Pierce, Rockford, IL) or transferred to 
0.45µm pore size PVDF membranes (Millipore Immobulon-P). Note: detergent fractions in 
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6x loading buffer were diluted 1:1 with 1x loading buffer prior to electrophoresis to prevent 
detergent-effects on protein mobility. 
Transfer and Western Blotting: 
Electrophoresis gels were transferred to PVDF membranes using a semi-dry transfer 
system (Owl, Thermo Scientific, Rochester, New York) at 2 mA/cm2 for 2 hours in Towbin 
buffer (0.025 M Tris pH 8.3, 0.192 m glycine, 20% methanol). SDS-PAGE blots were 
incubated in 1X Tween 20 Tris Buffered Saline buffer (TTSB, 50 mM Tris pH 7.4, 150 mM 
NaCl, 5% Tween-20) supplemented with 5% non-fat dry milk for 1 hour at 4°C. Blue Native 
PAGE blots were first de-stained in 100% methanol until excess Coomassie was removed 
and then incubated in 1X TTSB with 5% milk. Membranes were then incubated with 5-10 ml 
of primary antisera (or antibody) solutions in a vacuum sealable bag overnight at 4°C. 
Antisera dilutions used were as follows: anti-PSA rabbit antisera [66] 1:1,000, anti-MSP 
sheep antisera [88] 1:5,000, complement protein antibodies 1:1,000 (Complement 
Technologies, Tyler, Texas). Blots were washed in 1X TTSB 4 times for 5 minutes each and 
then incubated with appropriate (anti-goat, anti-rabbit, or anti-sheep) secondary perioxidase-
conjugated antibodies (Pierce, Rockford, IL) in the following dilutions: 1:10,000 anti-goat, 
1:10,000 anti-rabbit, and 1:15,000 anti-sheep. Antibody or antisera binding was visualized by 
enzyme linked chemiluminescence per instructions (SuperSignal West Pico, Pierce, 
Rockford, IL). 
Results: 
Stationary phase cells resist CML while log phase cells are susceptible: 
Logarithmic and stationary phase cells were treated with 25% naïve human serum to 
expose parasite surface molecules to the complement cascade and to validate that log phase 
20 
cells were susceptible and stationary phase cells were resistant to CML. Log phase cell 
cultures (Figure 1) reached a cell density of 7.05-7.35 x 106 cells/ml on day 2 of growth and 
survived 25% serum in the range of 4%-33%. Stationary phase cell cultures grew to a cell 
density of 4.85-5.65 x 107 cells/ml on day 5 of growth and survived at levels exceeding 100% 
(Figure 1). Survival rates above 100% relative to no-serum controls were consistently seen in 
stationary phase cells; average percent survival for log phase cells was 16.56% and 122.82% 
for stationary phase cells. 
PSA Mobility is not affected by exposure to Naïve Human Serum 
High PSA expression levels have been shown to be positively associated with 
virulence in metacyclic promastigotes, the predominant form of L. chagasi in stationary 
phase cultures, but it is not known if PSA is involved with complement evasion. The purpose 
of this experiment was to determine in serum-exposed cells whether PSA formed heteromers 
with (or was otherwise modified by) complement proteins that would be evidenced by a 
change in the gel mobility of PSA in either SDS-PAGE or Blue Native PAGE formats. 
Triton X-114 phase separated fractions (diagrammed in Figure 2) were resolved using 
reducing Blue Native PAGE or SDS-PAGE (Figure 3A and 3B respectively).  The Triton X-
114 phase separation successfully enriched GPI anchored surface molecules as evidenced by 
enrichment of PSA in the detergent phase when compared to total lysates (Figure 3, Lanes 7 
and 10 vs. 5 and 8) or the aqueous phases (Figure 3, Lanes 1, 3, 6, and 9). This result was 
expected, as the ability for Triton X-114 to enrich GPI anchored molecules in Leishmania is 
very well documented [50, 53, 89]. Greater amounts of PSA were present in stationary phase 
cells than in log phase cells, including the PSA-enriched detergent fractions of TX-114 phase 
separation (Lanes 2 and 5 vs. 7 and 10). This  indicated that stationary phase cells have 
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greater amounts of PSA than log phase cells (as previously observed, [74])  and that PSA 
was enriched in the TX-114 detergent pellet. 
Three distinct bands of 58, 33, and 20 kDa were detected using PSA antisera after 
resolution with SDS-PAGE (Figure 3B) and the same banding pattern of PSA was observed 
in untreated and serum exposed stationary phase cells (3B, Lane 7 vs. 10). Three distinct 
PSA bands of unknown size were detected after resolution with Blue Native PAGE (3A, 
Lanes 5, 7, 8, and 10) and the PSA signal was identical in the absence and presence of serum 
(Figure 3A, Lanes 5 and 7 vs. 6 and 10, respectively). The PSA antisera detected proteins in 
naïve human serum (Figure 3A, Lane 14) that were different from those observed in samples 
that contained parasite proteins; this was attributed to the cross-reactivity of the antisera with 
proteins present in serum, which has been previously observed [66].  Detection of the cross 
reactive bands was eliminated once cell pellets were washed in PBS or other buffers 
(Scolaro, unpublished). 
In summary, no detectable change in the mobility of PSA from stationary phase 
parasites was observed in the absence or presence of human serum in either PAGE format 
(Figure 3, Lane 5 vs. Lane 9) regardless of TX-114 fraction and amount of PSA signal.  
Thus, if PSA interacted with serum proteins, then evidence of interaction it is not detectable 
under these conditions. 
MSP Mobility is not affected by exposure to Naïve Human Serum 
MSP has been previously identified as a molecule important for the virulence of 
Leishmania  parasites; functionally, it has been shown to convert C3b into iC3b in in vitro 
reactions [41] but MSP has not been shown to interact with complement proteins in a parasite 
based assay [29]. The following experiment was performed to determine if the 
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electrophoretic mobility of MSP from log and stationary phase cells is altered after treatment 
of cells with naïve human serum.  
More MSP was localized in the detergent fraction than in the total lysate 
demonstrating successful concentration of GPI anchored molecules (Figure 4). Triton X-114 
phase separation enriched MSP in the detergent fraction of both log and stationary phase 
cells when strength of signal was compared to total lysate and aqueous fractions (Figure 4, 
Lanes 2, 4, 7, and 10 versus Lanes 1, 3, 5, 6, 8 and 9). The log phase cells expressed less 
MSP when compared to stationary phase cells (Figure 4, Lanes 1-4 versus Lanes 5-10).  
The MSP banding pattern seen in stationary phase cell fractions and log phase cell 
fractions after SDS-PAGE was no different after exposure to naïve human serum (Figure 
4B). The primary bands of MSP seen when protein fractions are resolved using SDS-PAGE 
(Figure 4B) are indicated by the molecular weights listed next to the figure. The same 
parasite fractions were subjected to Blue Native PAGE, and the same result was seen with no 
detectable shift in MSP mobility after serum exposure in both log (Figure 4A, Lanes 1-2 vs. 
3-4) and stationary phase cells (Figure 4A, Lanes 5-7 vs. Lanes 8-10). No change in the 
mobility of MSP from stationary and log phase parasites was observed in the absence or 
presence of human serum in either PAGE format regardless of TX-114 fraction and amount 
of PSA signal.  If MSP interacted with serum proteins, then evidence of interaction it is not 
detectable under these conditions. 
 The banding pattern of MSP through a Blue Native PAGE gel was observed to be a 
distinct pattern of 5 bands. When the MSP of log and stationary detergent phases are 
compared, log phase fractions only have 2 bands present while stationary phase fractions 
have all 5 bands present (Figure 4A, Lanes 2 and 4 vs. Lanes 7 and 10, respectively). This 
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reinforced existing evidence that MSP is present as different isoforms in the various growth 
phases [83, 86]. This study provides the first report of the resolution by native gel separation 
of different MSP isoforms from different growth phases. This finding could allow for the 
isolation of different subunits/isoforms of native MSP and a characterization of 
subunit/isoform protease activity. 
Characterization of C5 binding to log phase and stationary phase cells 
Complement protein C5 forms the C5 convertase of the complement cascade, which 
is the first step in formation of a MAC; differences in the abundance of C5 on log and 
stationary phase parasites after exposure to human serum could give insight into the 
mechanism(s) of complement evasion. The same protein fractions and PAGE separation 
techniques used in PSA and MSP studies were used to compare by western blot the 
characteristics of C5 bound to log phase and stationary phase cells. 
Complement protein C5 has a distinct banding pattern of 58, 46, 30, and 23 kDa 
(Figure 5B) after resolution with SDS-PAGE, and was identical in both log and stationary 
phase cells (Figure 5B, Lanes 1-4 and 5-10, respectively). C5 was enriched in the aqueous 
phases of both log and stationary phase cells (Figure 5B, Lanes 3 and 9), when compared to 
the C5 signal in total lysates of stationary phase cells (Figure 5B, Lane 8). Based on strength 
of signal, more C5 was present in the aqueous phase of log phase cells than in stationary 
phase cells (Figure 5B, Lane 3 vs. 9). The serum-only lanes (Figure 5B, Lanes 12-14) and 
detergent fractions (5B, Lanes 4 and 10) had very low signal and were detected only with 
high exposure times and electronic enhancement (data not shown).  
Blue Native PAGE resolution showed a C5 banding pattern of 3-4 bands in both log 
and stationary phase cells (Figure 5A, Lanes 3 and 9), with more C5 in the aqueous phase 
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than detergent phase or total lysate in both cell types (as was observed in SDS-PAGE results 
of Figure 4). Log phase cell fractions had a lower migrating band that was not clearly 
discernable in stationary cell fractions (Figure 5A, Lanes 3-4 vs. 8-10). C5 was detected in 
the detergent phases of both cell types with the same banding patterns as the corresponding 
aqueous phases when compared (Figure 5A Lanes 3 vs. 4, 9 vs. 10); more C5 was detected in 
the detergent phase of log phase cells than stationary (Figure 5A, Lane 4 vs. 10).  In serum 
only fractions (Figure 5A, Lanes 12-14) there was significant C5 signal seen in all three 
lanes; a lower migrating C5 band was observed in a serum-only fraction (Figure 5A, Lane 
13) that corresponds with bands seen in all other C5-containing fractions (indicated by the 
arrowheads, Figure 5A, Lane 13 vs. 3) but was not seen in all serum only.  
In summary, while C5 was enriched in the aqueous phases of both cell types, more 
C5 was detected on log phase cells. A small amount of C5 partitioned to the detergent phase 
of both cell types. There was a unique isoform of C5 present under Blue native separation of 
log phase cell lysates that was not seen in serum only fractions, indicating a possible 
difference in how C5 binds log and stationary phase cells. 
Characterization of C9 binding to log phase and stationary phase cells 
Complement protein C9 is the last protein of the complement cascade and is the most 
abundant molecule in the MAC [24]; all previous steps of the complement cascade have to be 
completed for the insertion of C9 into cell membranes. Differences in the abundance of C9 
on log and stationary phase parasites after exposure to human serum could give insight into 
the mechanism(s) of complement evasion. The same protein fractions and PAGE separation 
techniques used in PSA and MSP studies were used to compare by western blot the 
characteristics of C5 bound to log phase and stationary phase cells. 
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Most of the detectable C9 in fractions resolved with SDS-PAGE was found in the 
aqueous phase of log and stationary phase cells as well as the serum only lanes (Figure 6B, 
Lanes 3, 9, 12-14, respectively); more C9 was detected in the aqueous phase of log versus 
stationary phase cells based on the strength of signal. Low amounts of C9 were detected in 
the serum only lanes, and no difference was seen in serum only lanes (Figure 6B, Lanes 13, 
12 and 14, respectively). The same banding pattern observed for C9 after resolution with 
SDS-PAGE was seen in both log and stationary phase cells, indicating that C9 on log and 
stationary phase cells was not differentially modified on these cell types. That said, C9 
appears to be present in greater amounts in the log phase cells (Figure 6B, Lane 3 vs. Lane 
9).  When the cell-lysate samples were resolved with Blue Native PAGE, C9 was observed as 
three bands, one intense/abundant extremely low mobility band that failed to appreciably 
migrate into the gel, and two higher motility bands of lower intensity/abundance (Figure 6A).   
An interesting observation was made in the analysis by Blue Native PAGE of serum 
that had, or had not, been previously exposed to cells.  All three of these samples exhibited 
abundant C9 presence, but the mobility of the C9 was strikingly different among the samples 
(Figure 6A, Lanes 12-14).  Stationary phase serum-only had one lowly mobile C9 band 
(Figure 6A Lane 13).  Log phase serum-only had low levels of the low mobility band but had 
a large amount of higher mobility bands.  Naïve serum-only (Figure 6A Lane 14) had the 
least of the low mobility C9, and the most of the higher mobility C9 bands.  This experiment 
demonstrates that incubation of serum at 37°C was, alone, not sufficient for formation of 
large amounts of the low mobility C9 (Fig. 6, lane 14), and therefore that formation of the 
low mobility C9 is dependent on the presence of log or stationary parasites, and occurs to a 
greater degree with stationary parasites. 
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In summary, while no difference was observed under either PAGE technique in the 
deposition of C9 to log phase and stationary phase cells, exposure of serum to cells resulted 
in enhanced abundance within the serum of low mobility C9 when samples were assessed 
under Blue Native PAGE.  One possible explanation is that the low mobility Blue Native 
PAGE C9 is comprised of C9 complexed with the other components of the MAC; these also 
appear within cell lysates and serum exposed to cells may indicate that some number of 
MACs are shed from the parasite.  Alternatively, the C9-MAC complex that appears in the 
cell exposed serum-only fractions may derive from C9-MAC that reacted with parasite 
macromolecules (e.g. secreted proteophosphoglycans) that are either only loosely associated 
with the cell surface or are not associated with the cell surface. Within naive serum C9 exists 
as any of a number of forms having different electrophoretic mobility under Native Blue 
PAGE, and many of these forms can be seen in resolved in log serum-only, but not stationary 
serum-only fractions.   
Characterization of C3 binding to log and stationary phase cells 
Complement protein C3 has previously been shown to bind log and stationary phase 
cells equivalently and the C3 isoforms were equivalent as well [29] and it was hypothesized 
that no difference would be seen in C3 deposition on log and stationary phase cells. The 
purpose of this experiment was to determine in serum-exposed cells whether C3 formed 
heteromers with (or was otherwise modified by) complement proteins that would be 
evidenced by a change in the gel mobility of PSA in either SDS-PAGE or Blue Native PAGE 
formats.  
Upon resolution with reducing SDS-PAGE, there were large numbers of C3 bands 
detected in both log and stationary phase cells, with the majority of C3 being detected in the 
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aqueous phases of Triton X-114 separation in both cell types (Figure 7B, Lanes 3 and 9 
respectively), as seen previously with C5 and C9. Large C3 bands greater than 175 kDa in 
molecular weight were seen in both log and stationary phase fractions, but were not observed 
in all experimental replicates (not shown); this band has been seen in  previous studies [29] 
as well as previous studies performed in our lab (Ramer-Tait, Beetham Lab, unpublished 
data).  The primary C3 bands are near 58 kDa, 46 kDa, 31 kDa, and 28 kDa and were 
observed in log and stationary phase cell aqueous fractions, serum-only fractions (Figure 6B 
Lanes 3 and 9, 12-14, respectively). The arrowheads indicate a possible difference in the C3 
bound to the surface of log versus stationary phase cells; the 31 kDa C3 band is much more 
intense in log phase than in stationary phase (Figure 7B, Lane 3 vs. Lane 9). The lower 
molecular weight C3 bands (below 28 kDa) in log phase cell fractions did not have 
comparable signal to the stationary phase fractions which could be due to a number of 
factors, such as inefficient electro-transfer of low molecular weight proteins to PVDF (Figure 
7B, Lane 3 vs. 9). 
Blue Native PAGE was also used to investigate the banding pattern of C3 bound to 
log and stationary phase cells. Significantly more C3 was detected (based on strength of 
signal) in the detergent fractions of both growth phases after resolution with Blue Native 
PAGE than SDS-PAGE (Figure 7A vs. 7B, Lanes 4 and 10). The C3 banding pattern in 
parasite fractions was different than serum-only fractions (Figure 7A Lanes 1-10 vs. 12-14), 
indicating that C3 bound to parasites is different than C3 seen in serum-only fractions (Figure 
7A, Lanes 1-10 vs.  12-14). One isoform (Figure 7A, indicated by the arrowhead) had 
stronger signal in all log phase fractions than in stationary phase fractions and was absent in 
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serum-only, which indicated this isoform of C3 could be involved in CML (Figure 7A Lanes 
3-4, 13 (Log), Lanes 8-10, 13 (Stationary), and Lane 14 (Naïve serum)).  
The majority of C3 was in the aqueous fractions of both growth phases, and observed 
as bands of different sizes in log and stationary phase cells (Figure 7A, Lane 3 vs. 9). The 
lowest C3 band in the aqueous fraction of stationary cells may have migrated lower than in 
the aqueous phase of the log phase cells, indicating some difference in the C3 bound to the 
different cell types. There was a second C3 band detected in the aqueous phases of both log 
and stationary phase cells (Figure 7A Lanes 3 and 8) that was not detected in any serum-only 
fractions in (Figure 7A Lanes 12-14) which indicated that this form of C3 bound to the 
parasite was a product of parasite-C3 interactions. 
The results obtained using SDS-PAGE were not conclusive, as some C3 banding 
patterns observed in log and stationary phase fractions were not consistent from sample to 
sample. When the same fractions were resolved under Blue Native PAGE conditions 
numerous differences were observed, with the most interesting being the possible difference 
in size of C3 seen on the aqueous phases of log and stationary phase cells. Due to the 
inability to compare all replicates in the same gel in this experiment, and the unknown 
molecular weight of C3 in Blue Native PAGE, more experiments are necessary to clarify this 
result.  
Further characterization of C3 isoforms on log vs. stationary cells 
The aqueous phase samples containing serum and commercially available C3 
isoforms (Complement Technologies, Tyler, Texas) were resolved with Blue Native PAGE 
to allow for comparisons across replicates and determine if a difference in size of C3 
between log and stationary phase cells could be observed. 
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The aqueous fractions of log phase and stationary phase have different lower C3 
bands (Figure 8A, Lanes 4, 6, and 8 vs. Lanes 5, 7, and 9);  the isoform of C3 bound to log 
phase cells in the aqueous phase is larger than that of stationary phase cells. The larger C3 
band of log phase cells was also observed in serum-only fractions incubated at 37°C (Figure 
8A, Lanes 10-12), indicating that the lower migrating C3 isoform of stationary phase cells 
was different than those normally observed in functional naïve human serum.  
The same samples were resolved using SDS-PAGE to get a clear comparison of C3 
bands across parasite fractions and purified C3 proteins. Log phase cell fractions resolved 
with SDS-PAGE contained large amounts of iC3b when purified iC3b is compared to the 
aqueous fractions of log phase cells (Figure 8B, Lane 3 vs. Lanes 4, 6, and 8); C3b did not 
seem to be detected in the log phase fractions either (Figure 8B, Lane 2 vs. Lanes, 4, 6, and 
8).   
A 35 kDa species of C3 associated with iC3b (Figure 8A, Lane 3) was more 
prominent in the log phase fractions when compared to stationary phase fractions, as 
indicated by arrowhead set 1. Arrowhead set 2 indicates another difference seen between log 
and stationary phase cell fractions, that  with a 28-30 kDa species is present in greater 
amounts in log phase verses stationary phase cells; that particular band appears to present in 
purified C3 proteins (Figure 8A, Lanes 1-3) but in very low amounts compared to log phase 
cell fractions. Arrowhead set 3 indicates the presence of a C3 band of approximately 28 kDa 
that appears only in stationary cell fractions. The fourth set of arrowheads also indicates a 
band that is seen only in the stationary cell fractions, though it was present in low amounts. 
These observations verified observable differences in the C3 isoforms present on log and 
stationary phase cell types 
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Taken together, these studies of C3 indicate that the stationary phase cells have 
different species of C3 present that are not seen in log phase cells, serum fractions, and 
purified C3 proteins that can be resolved using Blue Native PAGE. Interestingly, the aqueous 
phase log cells contained more iC3b than stationary phase cells, as well as no detectable 
amount of C3b after resolution with SDS-PAGE, which was the opposite of what would be 
expected.   
Some differences in C3 banding patterns may have been disrupted by SDS-PAGE 
conditions as shown by the difference in the strength of iC3b signal from log to stationary 
phase serum-only after resolution with SDS-PAGE and Blue Native PAGE. More iC3b was 
present in stationary phase serum-only than in log phase serum-only upon resolution with 
Blue Native PAGE (Figure 8A, Lanes 10 and 11, respectively), though the two different 
serum fractions have similar amounts of iC3b after resolution with SDS-PAGE.  
Discussion: 
 
The goal of this study was to determine if the L. chagasi surface molecules MSP and 
PSA interact with complement proteins and also characterize the complement proteins 
deposited on log and stationary cells. This was assessed by looking for changes in mobility of 
the different molecules in two different PAGE systems, SDS-PAGE and Blue Native PAGE.  
PSA surface molecules of log and stationary L. chagasi do not have detectable 
changes in their mobility through reducing SDS-PAGE or Blue Native PAGE on a Western 
blot after exposure to naïve human serum. It was possible that a complex of PSA and 
complement proteins could be interrupted by the preparation of the proteins, the Triton X-
114 detergent itself, or by the loading buffers used for SDS and Blue Native PAGE. PSA has 
not been shown previously to interact with complement proteins and to date, no known 
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protein-protein interactions have been demonstrated with PSA. The molecule has been 
associated with Leishmania virulence and its signature motif is the leucine rich repeat (LRR), 
a domain that has been shown in many different organisms to be involved in protein-protein 
interactions of all kinds [45-46, 90-91]. Recombinant LRR from PSA has been shown to bind 
to macrophages; this suggests that the role for PSA in parasite virulence may not involve 
complement evasion [54]. This null result could be explained by the absence of protease 
inhibitors in the lysis buffer, which could allow protease activity, which could interrupt 
complement protein-surface molecule complexes. The lysates and serum fractions were flash 
frozen immediately addition of PAGE loading dye after Triton X-114 phase and samples 
were thawed on ice before electrophoresis, all of which should limit the amount of 
uninhibited protease activity.  
The majority of complement proteins bound to parasites was found in the aqueous 
phase of Triton X-114 phase separation and smaller amounts of complement proteins found 
in the detergent phase. The complement protein found in the detergent phase could be due to 
overloading of the Triton X-114 phase separation system and could be resolved by back-
extraction of the detergent phase material and determine if complement proteins are truly 
separating to the detergent phase. The majority of the complement proteins were in the 
aqueous phase and the majority of GPI anchored parasite proteins PSA and MSP were in the 
detergent phase, suggesting that GPI anchored proteins and complement proteins do not form 
complexes of molecules that are stable under the separation conditions used here.  It is 
unknown how Triton X-114 would affect the interactions between complement proteins and 
parasite proteins, but complement proteins have been shown to bind covalently to the surface 
of pathogens [28-29, 92-93], and the Triton series of detergents are non-ionic and should not 
32 
interrupt the covalent interactions It seems unlikely that Triton X-114 would break the 
covalent bonds of complement proteins with their acceptors; this possibility would have to be 
addressed before using TX-114 in a similar study. 
No difference in C5 and C9 isoform mobility accepted by log and stationary phase 
cell lysates were observed, and both had isoforms too large to migrate into Blue Native 
PAGE gels. The low mobility C9 complex was observed in human serum after incubation 
with stationary phase cells, while numerous smaller molecular weight isoforms of C9 were 
observed only in log phase serum-only and naïve human serum (Figure 5A, Lanes 12-14). 
The log and naïve serum-only fractions have the large C9 complex in common with 
stationary serum-only, though the band did not have as strong of a signal (Figure 5A, Lanes 
12-14).  This large complex could be a MAC, based on the number of molecules present in a 
MAC and the observed complexes of C3, C5, and C9 that were too large to migrate into the 
Blue Native PAGE gels. The stationary phase cells could be titrating unassembled or 
partially assembled MACs from the serum and in so doing could make the cells resistant to 
CML. The presence of the large complexes in the aqueous phases indicates the stationary 
phase parasites may evade CML through shedding of MACs or through other processes that 
cause C9 polymerization away from the cell.  The smaller forms of C9 seen in log serum-
only could represent MACs that are not fully assembled due to the inability of log phase cells 
to exhaust the supply of complement proteins because they cannot evade CML.  
C3 deposited on stationary cells, after partitioning to the aqueous phase during TX-
114 extraction, migrated further into Blue Native PAGE gels than all other C3 isoforms 
detected. The SDS-PAGE resolved parasite lysates revealed that the detectable C3 accepted 
to the log and stationary cells was primarily iC3b though four differences are observed and 
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could contribute to the change in mobility of C3 accepted to stationary phase cells in Blue 
Native PAGE. One difference between the log and stationary phases was a change in the 
iC3b accepted to their respective surface when compared to purified iC3b. Two isoforms of 
C3 that were not detectable in any other lanes were found in stationary phase cell fractions, 
indicating a possible modification of C3 upon deposition to the stationary parasite. Taken 
with the absence or decrease bands that were strongly associated with log cells (Figure 6B, 
arrowhead sets 1 and 2), there are subtle differences in how C3 is accepted to the different 
cells types.  
These studies were designed to determine if complement proteins are adsorbed to 
PSA and MSP on the surface of log and stationary phase parasites, and secondarily, to 
characterize deposited complement proteins on the different cell types. Complement proteins 
are indeed adsorbed to both forms of the parasite, though no detectable changes were seen in 
the parasite molecules studies. No differences between log and stationary cell in the 
acceptance of C5 or C9 were detected, though subtle differences in the isoforms of C3 were 
detected and the importance of these differences remains to be seen. The use of Blue Native 
PAGE has not been described in literature thus far for resolution of Leishmania total lysates 
or for fractions enriched for the presence of GPI anchored proteins, and will allow for future 
studies of Leishmania proteins separated in a native gel electrophoresis system.
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Figure 1: Stationary phase cells resist CML while log phase cells are susceptible 
Log and stationary phase cells were exposed to 25% naïve human serum and were assayed for survival after 30 
minute incubation at 37°C. Survivors were counted on a light microscope, using a hemocytometer to determine 
cell density. Error bars indicate calculated standard deviation of 3 experiments with average values of 16.74% 
for log phase cells and 6.53% for stationary cells. 
 
Figure 2: Triton X-114 phase separation diagram 
Log and stationary cells were exposed to 25% naïve human serum for 30 minutes at 37°C, pelleted at 5000 X G, 
and washed by resuspension in 0.5 ml PBS three times. Cell pellets were resuspended in 1% Triton X-114 
(PBS) and incubated for 2 hours at 4°C. Insoluble proteins were pelleted at 14,000 X G; supernatant was saved 
and layered over 6% sucrose cushion and incubated at 37° C for 30 minutes. Detergent phase of Triton X-114 
lysates were pelleted at 10,000 X G for 3 minutes. Diagram shows all the steps after cell lysis in 1% Triton X-
114. 
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Figure 3: PSA mobility is not affected by parasite exposure to naïve human serum  
 
Cell lysates (1 µg per lane) were separated by 10% Blue Native PAGE gels (Panel A) or 10% SDS-PAGE gels 
(Panel B), electrophoresed, transferred to PVDF membrane, and probed with anti-PSA antibody. Each panel 
represents an experimental replicate. The rubric above the blots denotes which protein fraction is present in 
each lane, and molecular weights of SDS-PAGE resolved proteins are indicated to the left of Panel B. Lanes 12 
and 13 are naïve human serum that has been incubated with stationary and log phase cells respectively, and do 
not include cells. Rubric is as described in Figure 2.   
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Figure 4: MSP mobility is not affected by parasite exposure to naïve human serum  
 
Western blots probed with antisera against MSP after resolution of 1 µg total protein with either Blue Native 
PAGE (Panel A) or SDS-PAGE (Panel B). Each panel is representative of 3 replicates. Lanes 12 and 13 are 
naïve human serum that has been incubated with stationary and log phase cells respectively, and do not include 
cells.  Rubric is as described in Figure 2.   
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Figure 5: Characterization of C5 binding to log phase and metacyclic phase cells 
 
Western blots probed with antisera against C5 after resolution of 1 µg total protein with either Blue Native 
PAGE (Panel A) or SDS-PAGE (Panel B). Each panel is representative of 3 replicates. Arrowhead indicates an 
identical band. Lanes 12 and 13 are naïve human serum that has been incubated with stationary and log phase 
cells respectively, and do not include cells. Rubric is as described in Figure 2.   
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Figure 6: Characterization of C9 binding to log phase and metacyclic phase cells 
 
Western blots probed with antisera against C9 after resolution of 1 µg total protein with either Blue Native 
PAGE (Panel A) or SDS-PAGE (Panel B), each panel representing an experimental replicate. Lanes 12 and 13 
are naïve human serum that has been incubated with stationary and log phase cells respectively, and do not 
include cells. Rubric is as described in Figure 2.   
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Figure 7: Characterization of C3 binding to log and stationary phase cells 
 
Western blots probed with antibodies against C3 after resolution of 1 µg total protein with either Blue Native 
PAGE (Panel A) or SDS-PAGE (Panel B), each representative of 3 experimental replicates. Lanes 12 and 13 
are naïve human serum that has been incubated with stationary and log phase cells respectively, and do not 
include cells. Rubric is as described in Figure 2.   
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Figure 8: Further characterization of C3 isoforms on log vs. stationary cells 
 
The aqueous phase of serum exposed log and stationary phase cells of 3 cell lines were resolved with either 
Blue Native PAGE (Panel A) or SDS-PAGE (Panel B) and Western blots were probed with antisera against C3 
after resolution of 1 µg total protein. Purified C3 proteins were also included in the analysis, with C3 in Lane 1, 
C3b in Lane 2, and iC3b in Lane 3. Lanes 12 and 13 are naïve human serum that has been incubated with 
stationary and log phase cells respectively, and do not include cells. 
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Abstract: 
Serial passage of axenically-cultured Leishmania chagasi promastigotes results in a 
progressive diminution in resistance to complement mediated lysis (CML), whereas high 
CML resistance is seen in infectious metacyclic promastigotes from the sandfly vector as 
well as metacyclic-like promastigotes within low passage cultures at stationary growth phase. 
As previously reported [94], in a screen seeking to identify novel genes involved in CML-
resistance, (i) a genomic cosmid library derived from DNA of CML-resistant L. chagasi 
promastigotes was transfected into high passage (constitutively CML-sensitive) L. chagasi 
promastigotes, (ii) transformants were screened for acquisition of CML-resistance, (iii) 
multiple cosmid-transfectants exhibited partial CML resistance, and (iv) the sequence for one 
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of the cosmids (Cosmid 51) was determined. The present report extends the analysis of 
Cosmid 51, and identifies by deletion analysis a sub-region of the cosmid insert that is 
critical to the CML resistance phenotype of Cosmid 51 transformants. We also report the 
sequence determination and initial CML-resistance activity of another cosmid that also 
confers partial resistance to CML.  
Introduction 
  Leishmania spp are the etiological agents of the leishmaniases, a group of human and 
animal diseases ranging in severity from self-healing cutaneous lesions to potential fatal 
visceral infections. Transmission occurs when a parasitized blood-feeding sandfly inoculates 
infectious metacyclic promastigote-form parasites into a mammal or other susceptible 
vertebrate. Inoculated metacyclic promastigotes are phagocytosed by macrophages and other 
phagocytic cells of the immune system, cells in which the parasites differentiate into 
amastigote-form parasites that comprise the replicative stage within the mammal.   
During the time between inoculation and macrophage phagocytosis, metacyclic 
promastigotes need to survive exposure to complement, an antimicrobial innate immune 
defense system present in serum. Complement involves a cascade of serum-protein binding 
events that can result in formation on the microbe of a membrane attack complex that kills by 
disrupting the outer membrane. Metacyclic promastigotes are thought to survive such 
complement mediated lysis (CML) through at least three mechanisms: proteolytic 
inactivation of the complement cascade, fast release of membrane attack complexes, and a 
glycocalyx structure that causes membrane attack complex assembly too distal to the parasite 
membrane. Three highly abundant and developmentally regulated parasite surface 
macromolecules are thought to be involved in this resistance. Major Surface Protease (or 
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GP63) is thought to cleave complement C3b into an iC3b-like form able to block the 
complement cascade while still functioning as an opsinogen able to facilitate parasite 
phagocytosis into macrophages via receptor CR3 [57]. Lipophosphoglycan (LPG) may be 
involved in ineffective positioning/assembly of the MAC [95]. Promastigote surface antigen 
(PSA, or GP46) re-expression in promastigotes having an otherwise low PSA expression 
level and low CML survival resulted in greatly increased resistance to CML [96]. The high 
CML-resistance that is characteristic of metacyclic promastigotes does not apply to the other 
promastigote stages, including the procyclic, that are present in the insect host and in axenic 
promastigote cultures [97-100]. 
The promastigote stages (e.g. the insect stages) of Leishmania species including 
Leishmania chagasi can be cultured in vitro axenically (in the absence of the fly vector). 
Infectious parasite cultures are established using amastigotes freshly isolated from 
parasitized, symptomatic animals; the amastigotes quickly differentiate into promastigotes 
under appropriate conditions [86, 101]. However, serial passage of promastigote cultures 
results in a progressive diminution in parasite capacity to infect and to resist CML [57, 102]. 
Based upon these observations, a gene add-back complementation study was undertaken to 
determine whether high passage CML-sensitive cells could be used as a genetic background 
against which to screen for parasites able to resist CML. The aim of the experiment was to 
identify novel molecules involved in CML-resistance, molecules in addition to MSP, PSA, 
and LPG. The initial results of the experiment as previously reported determined that when 
high passage parasites were transfected with cosmids containing approximately 35kb of L. 
chagasi genomic DNA, and then selected with human serum, ≈12 different cosmids were 
identified as conferring partial CML resistance; the sequence and annotation for one of these 
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cosmids, Cosmid 51 (previously referred to as Cosmid 2), was also reported [94]. The 
present report extends the cosmid analysis. 
Experimental Procedures 
L. chagasi (strain MHON/BR/00/1669) maintenance in hamster and in vitro promastigote 
cultivation were as described previously [86, 94, 101]. Low passage cells were serially 
passaged ≤ 4 times subsequent to culture initiation with hamster-derived freshly isolated 
amastigotes. High passage cells were passaged for > 50 weeks; 1 week ≈ 1 passage. 
Cosmid construction, manipulation, transfection into L. chagasi, and screening for 
CML-resistance of transfectants were as described previously [94]. A 3x coverage of Cosmid 
53 sequence was determined by the Iowa State University DNA Facility utilizing a shotgun 
strategy by which 2kb fragments of randomly sheared cosmid were inserted into a plasmid, 
and then randomly selected plasmids were sequenced; sequence gaps were filled using 
specific primer-directed sequencing. 
For complement assays, promastigotes from cultures in stationary growth phase were 
incubated 30 min at 37°C in PBS supplemented with pooled naive human serum, then diluted 
in cold PBS and viewed microscopically to assess and enumerate survivors (as described) 
[94]. 
Results and Discussion 
The Cosmid 53 insert sequence of 40 kb was determined by shotgun sequencing (see 
methods; GenBank Accession DQ418548). BLAST comparison to Leishmania major and 
Leishmania infantum genomes indicated its correspondence to their chromosome 36. There is 
very high synteny and sequence identity between these two genomes, and correspondingly 
between them and that of the L. chagasi genomic DNA comprising the Cosmid 53 insert. We 
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previously reported the 32 kb sequence (Accession AY656839) and chromosome 36 
correspondence of the Cosmid 51 insert [94]. Although both cosmid inserts correspond to 
Chromosome 36, they have quite separated locations on the chromosome; Cosmid 53 
corresponds approximately to L. infantum chromosome 36 bases 284,000 to 309,000, and 
Cosmid 53 to base 1,190,000 to 1,230,000. Gene predictions, based upon the L. infantum 
genome annotation, indicate that Cosmid 51 comprises 1 partial (51-A) and 6 complete (51-B 
to G) genes, and that Cosmid 53 comprises 1 partial (53-M) and 12 complete (53-A to L) 
genes (Fig. 1). Table 1 lists the detail information on the gene predictions depicted in Fig. 1; 
in column headed “L. infantum V3 Chr 36”, “V3” refers to genome version 3, and “Chr” to 
Chromosome. Many of the genes are identified as hypothetical (hp), indicating that the 
deduced protein sequence is without identifiable homologs within gene databases in the 
public domain.   
Since parasite resistance to CML involves surface interactions with complement 
proteins, surface-localization is a possible characteristic of proteins that directly function in 
CML resistance. None of the predicted genes in Table I encode proteins having a 
hydrophobic signal peptide that would signal for translation on the rough endoplasmic 
reticulum, a requisite for almost all surface-located proteins. However, it is also possible for 
CML resistance to be conferred by genes that indirectly affect the expression of surface 
macromolecules, or affect other aspects of cell biology including surface membrane turnover. 
Predicted genes 53J and K encode proteins with possible function in outer membrane events 
and in RNA processing; the putative mRNA processing protein is of interest since it could 
function in modulating expression of surface proteins whose abundance is regulated by 
RNA-processing events that influence RNA steady-state levels. 
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To further investigate sequences that function in complement resistance, a set of 
Cosmid 51 subclones were made by opening the cosmids using insert-specific DNA 
restriction endonucleases, then re-ligating the cosmids and determining which resulting 
subclones had “squeezed out” the insert region targeted for removal (Fig. 1). Cosmid 51 
subclones were transfected into high passage complement sensitive parasites and resulting 
clonal isolates were tested for CML resistance. As shown in Fig. 2, deletion of the BamHI to 
BamHI insert fragment, which deletes all predicted genes, results in abrogation of almost 
70% of the CML resistance activity relative to that of Cosmid 51, while deleting the ApaI to 
ApaI or EcoRV to EcoRV fragments had no significant effect on relative CML resistance. 
The negative controls included non-transformed high passage (HP) cells and cells 
transformed with a cosmid from which the entire insert was removed; both controls had 
extremely low relative CML resistance levels (Fig. 2).  
Fig. 1 also depicts a similar strategy using deletion analysis for investigating Cosmid 
53. However, data is not shown because these studies are still in progress.  
 These experiments are expanding our understanding of genetic elements and proteins 
that function in CML resistance. Perhaps as importantly, the studies are needed in order to 
test the utility of using the gene complementation strategy for identifying CML resistance 
genes. If the approach proves useful, it has application in the study of the CML-resistant 
phenotype that is a trait of almost all blood-borne microbes. 
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Figures and Tables 
 
Table 1.  Cosmid gene predictions (based upon L. infantum genome). 
Cosmid 
gene 
L. infantum 
V3 Chr 36  
Predicted gene/protein 
51-A 0840 hypothetical protein (hp) 
51-B 0850 hp 
51-C 0860 hp 
51-D 0870 hp 
51-E 0880 ADP-ribosylation factor-like protein 
51-F 0890 hp 
51-G 0900 hp 
53-A 3090 hypothetical protein (hp) 
53-B 3100 succinyl-CoA ligase [GDP-forming] 
beta-chain, putative 
53-C 3110 hp 
53-D 3120 hp 
53-E 3130 hp 
53-F 3140 GTP-binding protein, putative 
53-G 3150 ATP-dependent RNA helicase, 
putative 
53-H 3160 glutathione peroxidase, putative 
53-I 3170 exosome complex exonuclease RRP41, 
putative 
53-J 3180  clathrin coat assembly protein-like 
protein 
53-K 3190 pre-mRNA branch site protein p14, 
putative 
53-L 3200 hp 
53-M 3210 cullin-like protein 
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Fig. 1. Cosmid 51 and 53 gene organization and subcloning strategy.  Rectangles beneath 
letters indicate predicted genes, arrows indicate orientation of predicted gene transcripts, 
“cLHyg ” indicates vector backbone, faint narrow lines indicate regions predicted to be 
non-protein coding. Solid double-arrowed lines indicate insert-regions targeted for deletion 
in specific subclones. 
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Fig. 2.  Complement resistance of cells transfected with Cosmid 53, 51, and 51-
subclones.  The percentage of cell survival, relative to survival of cells transfected with 
Cosmid 51, was calculated as the ratio of motile cells present after incubation with, versus 
without, 12% serum.   
Error bars indicate the standard error of the mean of at least three experiments. 
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Chapter 4: Notes 
 
Characterization of high passage cell lines 
Long term cell culture of Leishmania chagasi promastigotes obtained from 
amastigotes maintained in male Syrian Golden hamsters, is associated with a progressive loss 
of the ability to resist complement mediated lysis (CML) and loss of the expression of 
molecules associated with virulence. Promastigote surface antigen (PSA) has been associated 
with the virulence of Leishmania due to its abundance on the cell surface [89], presence in 
the genome of various species of Leishmania [49, 61, 103], recognition by sera from infected 
canines [104], possible interactions with macrophages [54], and leucine-rich-repeats that it 
has in common with other molecules important for parasite virulence [18, 43, 54, 104-105]. 
Upon serial passage of cell cultures, expression of PSA protein and mRNA is lost [66], and is 
only regained upon expression of recombinant PSA [55]. Due to this observation, a large 
scale genetics approach was used to identify genes involved with CML resistance, by 
transfection of a high passage CML sensitive strain of L. chagasi with the genomic library of 
35 kDa genomic DNA fragments from a low passage CML resistant cell line. After 
transfection of the high passage line, the cells were allowed to recover and then exposed to 
naïve human serum before plating for colony isolation. Numerous colonies were screened for 
the ability to restore CML resistance, and it was found that a number of isolates containing 
unique genomic DNA inserts could confer recovery of partial resistance to CML [73-74]. 
Numerous inserts were characterized, and isolates that conferred the highest amount of CML 
resistance to high passage cells were sequenced using a shotgun sequencing strategy. The 
sequenced isolates were then subjected to subcloning, using various restriction enzymes to 
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cut out pieces of the large insert in an attempt to isolate the regions within the 35 kDa isolate 
that were conferring resistance to the susceptible strain, with the ultimate goal of finding 
genes involved with virulence. Cosmids 51 and 53 are two such isolates, and a study has 
already been done on Cosmid 51 that identified a smaller portion of the insert as the region 
responsible for the majority of the recovered resistance CML [73]. The following studies 
describe the efforts of similar studies the author has done with Cosmid 53.  
Cosmid 53 was transfected into the 4L243-99 high passage L. chagasi cell line, as 
using methods previously described [73-74], and clonal isolates were obtained. Numerous 
clonal isolated were assayed for their ability to resist CML, and after multiple assays, it was 
determined that none of the isolates transfected with Cosmid 53 could confer any significant 
CML resistance. The transfection into 4L243-99 was repeated multiple times, and the same 
results were obtained. Cosmid 51 was treated as the positive control for the ability to restore 
CML resistance, and transfection into 4L243-99 was also attempted, and yielded the same 
inability to restore CML resistance. Multiple assays were attempted with the same set of cells 
with different members of the lab attempting the assay, and it was found that there was no 
difference in the results, showing that the assay was working and the transfection was not. 
The next step was to verify these transfected strains by recovering cosmid DNAs and verify 
or determine which cosmid DNAs were actually present in the high passage strain. Cosmids 
from numerous transfected strains that contained different cosmid DNAs were rescued from 
Leishmania and transformed into E. coli with unexpected results. The majority of the 
recovered cosmids did not contain the expected inserts, and the inserts that were contained 
were from strains that were not being passed in the. One cosmid recovered was one that had 
never been transformed into Leishmania in the laboratory before. A Southern blot was 
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designed to assess the different recovered DNAs from the various transfected parasites, and it 
was found that there were numerous cosmid constructs present in the recovered cosmid DNA 
population. Ancestral stocks of cosmids were obtained from the original genomic library [74] 
transfected into the same 4L243-99 strain of high passage cells, and upon recovery the same 
phenomenon was seen, and different cosmid molecules were obtained than from the original 
recovery. Cosmid 51 was recovered and verified by restriction enzyme digest, and 
transfected into multiple high passage cell lines and the same results were seen. No 
restoration of the ability to resist CML was seen, with none of the recovered cosmids 
containing the Cosmid 51 genomic DNA insert. This lead to a series of experiments designed 
to verify and characterize the numerous high passage cell lines in the lab to get a picture of 
what was going on. Southern blot of total genomic DNA showed that 6 of 9 high passage cell 
lines contained cosmid sequences, but conflicting results were obtained using the following 
methods. Polymerase chain reaction (PCR) was used to amplify cosmid specific sequences 
from the same total genomic DNA of high passage cell lines used in the Southern blot, and 
cosmid signal was detected in only 1 of 13 high passage isolates. DNA from the different 
high passage cell line was obtained in the same method as a cosmid rescue and cosmid rescue 
into E. coli was attempted, with none of the high passage cell lines returning any colonies, 
indicating the absence of transformable DNA elements in the tested cell lines. L.C. 50 was 
also done on these different high passage cell lines indicating the cell lines were not resistant 
to the drug used to select for the presence of cosmid. The 7L20 high passage cell line was 
used from this point on in the cosmid complementation studies, as it tested negative in all the 
above tests mentioned. 7L20 was then transfected with various DNA constructs, and all 
cosmids were successfully rescued from the transformants. Recovery of CML in these 
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isolates was highly variable in these transfected isolates, and led to discontinuation of this 
project as it was currently constructed. Other studies in the lab have found that transfection of 
the characterized 7L20 strain have yielded recovery of CML. The complementation project 
has been redesigned has a high-throughput screen of the genomic library that will be 
transformed into a fully characterized strain of 7L20 high passage cells. 
The background strain in which DNA is transfected into is paramount to the success 
of CML assay, but also successful transfection of Cosmid DNA. The lab now uses a different 
high passage cell line, changed the protocol for DNA transfection, and now fully 
characterizes high passage cells after each transfection. It is not fully understood how so 
many different DNA constructs were obtained from primary transformed cell lines. The 
4L243-99 and other high passage cell lines proved to be entirely unreliable for 
transformation due to unpredictable complement assay results and the variability of the DNA 
constructs rescued from the transformants. It was demonstrated that the 7L20 cell was 
suitable for consistent transformation, and later studies by other members of the lab 
determined that it is suitable for consistent CML assay results. These studies also helped 
determine the type of testing experiments that needed to accompany any transfection. 
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Chapter 5: General Conclusions 
 
Two different approaches were used in this study to gain insight into mechanisms used by 
Leishmania chagasi to avoid complement mediated lysis (CML). This group of studies 
outlines and refines a series of techniques that can be used to study Leishmania spp. parasites 
using both proteomics and genomics. The studies done in chapter 2 were an attempt to use 
two different types of PAGE to look for changes in the mobility of two parasite surface 
molecules, promastigote surface antigen (PSA), and major surface protease (MSP). No 
changes in the parasite molecules were seen, though some differences seen in the 
complement proteins accepted to log and stationary phase parasites. PSA and MSP were 
successfully resolved under native conditions using a technique called Blue Native PAGE, 
originally designed for the resolution of the extremely hydrophobic membrane proteins in 
mitochondria of various species. Native PAGE had been tried previously without any 
success, as parasite proteins would not migrate into the resolving gel, no matter what the pH 
or percentage gel used. When complement proteins were resolved using Blue Native PAGE, 
it was observed that there were large complexes that would not migrate into the resolving gel 
that were abolished upon resolution of the same protein samples with SDS-PAGE. The use of 
Blue Native PAGE as a first dimension of separation could allow for isolation of large 
protein complexes and the characterization of the protein make-up of these different 
complexes.  
The second study screened the genome of the parasite to identify genes that confer CML 
resistance to cell lines that were not able to resist CML. It was found that the high passage 
cell line 4L243-99 was an unreliable strain for use in transfection studies but that cell line 
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7L20 provided a reliable strain for transfection. The studies provided a framework in how to 
characterize a cell line for transfection before transfection, in an effort to avoid confounding, 
unexplainable results. 
Taken together, this group of studies outlines and refines a series of techniques that can be 
used to study Leishmania spp. parasites using both a proteomics and genetics approach.  
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